Inspire Medical Systems (NYSE:INSP) Insider Jason Kelly Sells 963 Shares of Stock

Inspire Medical Systems, Inc. (NYSE:INSP) insider Jason Kelly sold 963 shares of the company’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the transaction, the insider owned 18,985 shares of the company’s stock, valued at approximately $1,130,556.75. This represents a 4.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Inspire Medical Systems Stock Performance

Shares of INSP traded down $0.47 during mid-day trading on Tuesday, hitting $59.25. 385,365 shares of the stock were exchanged, compared to its average volume of 860,634. The company has a market cap of $1.71 billion, a PE ratio of 12.83, a price-to-earnings-growth ratio of 4.54 and a beta of 0.70. Inspire Medical Systems, Inc. has a 52-week low of $38.91 and a 52-week high of $147.03. The firm has a 50-day moving average of $48.39 and a two-hundred day moving average of $53.75.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.38. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The business had revenue of $200.58 million for the quarter, compared to the consensus estimate of $194.72 million. During the same period in the prior year, the business posted $0.45 earnings per share. The company’s quarterly revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, sell-side analysts predict that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Institutional Investors Weigh In On Inspire Medical Systems

Hedge funds have recently modified their holdings of the business. Daiwa Securities Group Inc. lifted its holdings in Inspire Medical Systems by 38.7% during the second quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock worth $60,000 after buying an additional 130 shares during the period. State of Wyoming lifted its stake in shares of Inspire Medical Systems by 31.5% during the 4th quarter. State of Wyoming now owns 731 shares of the company’s stock worth $67,000 after purchasing an additional 175 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in Inspire Medical Systems by 84.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after purchasing an additional 205 shares in the last quarter. Apollon Wealth Management LLC grew its stake in Inspire Medical Systems by 5.6% in the first quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company’s stock valued at $206,000 after purchasing an additional 212 shares during the last quarter. Finally, Blair William & Co. IL grew its position in shares of Inspire Medical Systems by 5.1% in the 3rd quarter. Blair William & Co. IL now owns 4,865 shares of the company’s stock worth $361,000 after buying an additional 234 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Wall Street Analyst Weigh In

INSP has been the topic of several recent analyst reports. Robert W. Baird raised their price target on shares of Inspire Medical Systems from $54.00 to $59.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. Zacks Research upgraded shares of Inspire Medical Systems from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Piper Sandler raised their target price on shares of Inspire Medical Systems from $55.00 to $60.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of Inspire Medical Systems in a report on Monday, August 3rd. Finally, Evercore set a $54.00 price objective on Inspire Medical Systems in a research note on Tuesday, August 4th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, thirteen have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $68.00.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.